Select Language

Search

Insights

No match found

Services

No match found

Industries

No match found

People

No match found

Insights

No match found

Services

No match found

People

No match found

Industries

No match found

BMO Hosts First Obesity Summit on Future of Obesity Care Market

resource image
News Releases Healthcare March 13, 2024
News Releases Healthcare March 13, 2024
  •  Minute Read Clock/
  • ListenListen/ StopStop/
  • Text Bigger | Text Smaller Text

 

  • Healthcare industry experts and leaders will convene at inaugural BMO Obesity Summit to examine outlook and trends in obesity treatment

NEW YORK, March 13, 2024 /CNW/ - BMO will host its first Obesity Summit on March 20, 2024, in New York City. The conference will target buy-side investors who want to hear from leading biotech and pharmaceutical companies developing medical weight-management therapeutics and stakeholders across the continuum of care and delivery. Topics straight from the headlines will be discussed via panels and presentations, including:

  • A panel on the emerging therapeutic landscape

  • The Patient's Voice: a conversation with patients on GLP-1+ therapy

  • Obesity 101 with Intellihealth, featuring Dr Katherine Saunders

  • Care delivery featuring Beth Israel Lahey Health, Weight Watchers, and Intellihealth

  • A key opinion leader's insights on metabolic research, featuring Weill Cornell Medical College's Dr Louis J. Aronne

  • A payors panel addressing coverage and access, featuring Prime Therapeutics

"Important conversations need to happen around the development and delivery of obesity care," said Evan Seigerman, Senior Biotechnology & Pharmaceuticals Analyst, BMO. "This summit is about having those discussions and sharing ideas and solutions from thought leaders and experts who can move the dial to meet challenges to deliver care for patients with obesity and metabolic disease."

BMO analysts, including Evan Seigerman, will host discussions with leading life sciences companies, including:

  • Altimmune

  • Amgen

  • Capital Rx

  • Corbus Pharmaceuticals

  • Eli Lilly & Co.

  • Novo Nordisk

  • Intellihealth

  • Prime Therapeutics

  • Scholar Rock

  • Structure Therapeutics

  • Terns Pharmaceuticals

  • Weight Watchers

For more information or to request an interview with one of BMO's equity research analysts, please contact BMO Media Relations using the contact details below. Note: There are restrictions for media on access to presentations and certain speakers.

About BMO Financial Group

BMO Financial Group is the eighth largest bank in North America by assets, with total assets of $1.3 trillion as of January 31, 2024. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society.

SOURCE BMO Financial Group

For further information: Media contact: Kelly Hechler, Toronto, kelly.hechler@bmo.com, (416) 867-3996

Read more

Conference

Healthcare Genetic Medicines Summit

July 9, 2024 New York

Email Us
Healthcare Oncology Summit

Oct. 8, 2024 New York

Email Us
Healthcare The BMO Obesity Summit

March 25, 2025 New York

Email Us

You might also be interested in